Molina Healthcare Analyst Day Recap

Molina Healthcare reaffirmed its long-term growth strategy at its Investor Day, targeting $25 EPS by 2029. Goldman Sachs maintains a Neutral rating, viewing the aggressive top-line targets as a risk to margin expansion.

Key Takeaways

• 1.Molina Healthcare introduced a long-term 2029 outlook targeting $64 billion in premium revenue and $25 in adjusted EPS, implying significant growth and margin expansion from a 2026 baseline.
• 2.Goldman Sachs maintains a Neutral rating, citing structural downside risks to margin targets due to the company's aggressive above-market top-line growth strategy.
• 3.The 2027 framework anticipates ~$48 billion in premiums and ~$9.50 EPS, which is notably higher than Goldman Sachs and consensus estimates.

Table of Contents

• Key Takeaways from Investor Day
• Medicaid
• Medicare
• Marketplace
• G&A
• Capital deployment
• Price Target & Key Risks
• Disclosure Appendix

Document Preview

Page 1 of 5

Subscribe for full accessStart Free Trial